Pacific Center for Financial Services’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3K | Sell |
550
-183
| -25% | -$3.75K | ﹤0.01% | 298 |
|
|
2025
Q1 | $15K | Sell |
733
-124
| -14% | -$2.54K | ﹤0.01% | 275 |
|
|
2024
Q4 | $19.4K | Buy |
857
+4
| +0.5% | +$91 | 0.01% | 257 |
|
|
2024
Q3 | $21K | Hold |
853
| – | – | 0.01% | 248 |
|
|
2024
Q2 | $19.7K | Buy |
853
+4
| +0.5% | +$92 | 0.01% | 243 |
|
|
2024
Q1 | $20.4K | Hold |
849
| – | – | 0.01% | 245 |
|
|
2023
Q4 | $19.5K | Buy |
849
+6
| +0.7% | +$138 | 0.01% | 230 |
|
|
2023
Q3 | $17.1K | Hold |
843
| – | – | 0.01% | 251 |
|
|
2023
Q2 | $19.7K | Buy |
843
+3
| +0.4% | +$70 | 0.01% | 234 |
|
|
2023
Q1 | $19.6K | Buy |
+840
| New | +$19.6K | 0.01% | 232 |
|
|
2022
Q3 | $22K | Hold |
840
| – | – | 0.01% | 216 |
|
|
2022
Q2 | $24K | Buy |
840
+4
| +0.5% | +$114 | 0.01% | 203 |
|
|
2022
Q1 | $29K | Sell |
836
-201
| -19% | -$6.97K | 0.01% | 193 |
|
|
2021
Q4 | $45K | Buy |
1,037
+325
| +46% | +$14.1K | 0.02% | 171 |
|
|
2021
Q3 | $36K | Buy |
+712
| New | +$36K | 0.02% | 184 |
|